Early research (Phase 1)Ended earlyNCT01907802
What this trial is testing
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction
Who this might be right for
BRAF Gene MutationHepatic ComplicationRenal Failure+1 more
National Cancer Institute (NCI) 8